Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q3 2021 · 10-Q
Revenue$10.56M$10.56M−0.7% vs Q3 2020 Net Income$1.54M$1.54MN/M vs Q3 2020 EPS Diluted$0.02$0.02— vs Q3 2020 Gross Profit$7,189,571+4.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,608,254N/M Free Cash Flowderived-$4,693,284N/M Margins · derivedGross margin68.1%+3.3 pt vs Q3 2020
Operating margin-63.2%−50.6 pt vs Q3 2020
Net margin14.6%+98.7 pt vs Q3 2020
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end